NK CellTech is a biotech company focusing on the discovery and development of innovative technology of NK cell therapy. The R&D team has over 30 years of experiences in the research and clinical practice of NK cells, which dedicates NK CellTech to become an international leading company in cellular immunotherapy. With our ABCDE-NK® platform (Allogeneic, Blood-derived, Cryopreserved Off-The-Shelf, Designed Genetically On Demand, Expanded to Clinical Scale) and SynNKTM platform (genetic logic gate technology of synthetic immunology), NK CellTech will deliver the innovative cellular drugs to precisely target broaden spectrum of tumors and harness the adaptivity to tumor immune microenvironment (TIME), leading to the consistent development of “intelligent” NK cell products to address the unmet clinical needs of cancer patients.